JP2021522789A5 - - Google Patents
Info
- Publication number
- JP2021522789A5 JP2021522789A5 JP2020561064A JP2020561064A JP2021522789A5 JP 2021522789 A5 JP2021522789 A5 JP 2021522789A5 JP 2020561064 A JP2020561064 A JP 2020561064A JP 2020561064 A JP2020561064 A JP 2020561064A JP 2021522789 A5 JP2021522789 A5 JP 2021522789A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- stem cells
- isolated stem
- virus
- scpv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862666013P | 2018-05-02 | 2018-05-02 | |
| US62/666,013 | 2018-05-02 | ||
| PCT/US2019/030488 WO2019213453A1 (en) | 2018-05-02 | 2019-05-02 | Stem cells comprising synthetic chimeric vaccinia virus and methods of using them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021522789A JP2021522789A (ja) | 2021-09-02 |
| JP2021522789A5 true JP2021522789A5 (https=) | 2022-05-12 |
Family
ID=68386182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020561064A Pending JP2021522789A (ja) | 2018-05-02 | 2019-05-02 | 合成キメラワクシニアウイルスを含む幹細胞およびそれらを使用する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210236619A1 (https=) |
| EP (1) | EP3787681A4 (https=) |
| JP (1) | JP2021522789A (https=) |
| CN (1) | CN112261951A (https=) |
| AR (1) | AR115070A1 (https=) |
| AU (1) | AU2019262150A1 (https=) |
| CA (1) | CA3098145A1 (https=) |
| TW (1) | TW202014200A (https=) |
| WO (1) | WO2019213453A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019535311A (ja) | 2016-11-02 | 2019-12-12 | デイビッド エバンス， | 合成キメラポックスウイルス |
| EP3788142A4 (en) * | 2018-05-02 | 2022-04-27 | Tonix Pharma Holdings Limited | SYNTHETIC CHIMERIC VACCINE VIRUS |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2503717C2 (ru) * | 2007-11-19 | 2014-01-10 | Трансжене Са | Поксвирусные онколитические векторы |
| CA2709292A1 (en) * | 2009-07-10 | 2011-01-10 | The Governors Of The University Of Alberta | Oncolytic viruses and methods for treating neoplastic disorders |
| ES2848650T3 (es) * | 2009-09-14 | 2021-08-11 | Sillajen Biotherapeutics Inc | Terapia combinada contra el cáncer con virus vaccinia oncolítico |
| WO2013083254A1 (en) * | 2011-12-09 | 2013-06-13 | Bavarian Nordic A/S | Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c |
| WO2014160475A1 (en) * | 2013-03-13 | 2014-10-02 | Aboody Karen S | Tropic cell based virotherapy for the treatment of cancer |
| CN107847534B (zh) * | 2015-04-17 | 2022-10-04 | 纪念斯隆凯特琳癌症中心 | Mva或mvaδe3l作为抗实体瘤的免疫治疗剂的应用 |
| CN108135996B (zh) * | 2015-08-11 | 2022-06-21 | 卡利迪生物治疗有限公司 | 用以癌症治疗的天花疫苗 |
| CN105535993A (zh) * | 2015-12-25 | 2016-05-04 | 浙江省人民医院 | 重组溶瘤痘苗病毒在治疗胃癌中的用途 |
| ES2702618B2 (es) * | 2017-09-04 | 2019-10-31 | Inst De Salud Carlos Iii | Producto de combinación que comprende una célula madre mesenquimatosa modificada y una sustancia antigénica. |
| WO2019213173A1 (en) * | 2018-04-30 | 2019-11-07 | City Of Hope | Neural stem cell compositions including chimeric poxviruses for cancer treatment |
-
2019
- 2019-05-02 CN CN201980029672.6A patent/CN112261951A/zh active Pending
- 2019-05-02 EP EP19797026.2A patent/EP3787681A4/en not_active Withdrawn
- 2019-05-02 TW TW108115294A patent/TW202014200A/zh unknown
- 2019-05-02 WO PCT/US2019/030488 patent/WO2019213453A1/en not_active Ceased
- 2019-05-02 US US17/049,741 patent/US20210236619A1/en not_active Abandoned
- 2019-05-02 CA CA3098145A patent/CA3098145A1/en active Pending
- 2019-05-02 AR ARP190101166A patent/AR115070A1/es not_active Application Discontinuation
- 2019-05-02 AU AU2019262150A patent/AU2019262150A1/en not_active Abandoned
- 2019-05-02 JP JP2020561064A patent/JP2021522789A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8772023B2 (en) | Promoters for recombinant viral expression | |
| JP2023515582A5 (https=) | ||
| US7638134B2 (en) | Insertion sites in fowlpox vectors | |
| JP2021522784A5 (https=) | ||
| Zhang et al. | The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14. 5L inactivation | |
| Guo et al. | Vaccinia as a vector for gene delivery | |
| US20220204992A1 (en) | Recombinant orf virus vector | |
| RU2009101382A (ru) | Процесс получения поксвирусов и композиции поксвирусов | |
| US20070275010A1 (en) | Mva Vaccines | |
| JP2019535311A5 (https=) | ||
| JP2014207903A5 (https=) | ||
| MX2022010588A (es) | Vacuna basada en poxvirus recombinantes contra el virus sars-cov-2. | |
| JP2021522789A5 (https=) | ||
| JP6235697B2 (ja) | 変異ワクシニアウイルス株、その使用およびそれを作製する方法 | |
| JP2025188115A (ja) | 新規遺伝子組換えワクシニアウイルス及びその利用 | |
| CN1723285A (zh) | 重组的mva及其产生方法 | |
| WO2010124393A1 (en) | Anticancer agent comprising a yatapoxvirus mutant and uses thereof | |
| Pacchioni et al. | Canarypox and fowlpox viruses as recombinant vaccine vectors: an ultrastructural comparative analysis | |
| Li et al. | Deletion of multiple genes induces virulence reduction of vaccinia virus Tiantan strain | |
| WO2025194263A1 (en) | Engineered cells for virus production | |
| WO2025157196A1 (zh) | 经修饰的痘苗病毒及其用途 | |
| CA3192853A1 (en) | Mutant orf viruses and uses thereof | |
| EA041611B1 (ru) | Рекомбинантный orf-вирусный вектор | |
| NZ752893A (en) | Synthetic chimeric poxviruses | |
| HK1211622B (zh) | 突变型痘苗病毒株、其用途及其制造方法 |